Epigenetic regulation of LSD1 during mammary carcinogenesis

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Inheritable epigenetic regulation is integral to the dynamic control of gene expression under different stimuli for cellular homeostasis and disease progression. Histone methylation is a common and important type of chromatin modification. LSD1, the first known histone lysine-specific demethylase, operates as a key component of several corepressor complexes during development and in disease states. In this review, we focus on the regulation of LSD1 in mammary carcinogenesis. LSD1 plays a role in promoting mammary tumor metastasis and proliferation and in maintaining mammary cancer stem cells. Therefore, LSD1 represents a viable therapeutic target for effective treatment of mammary carcinogenesis.

Original languageEnglish
Article numbere963426
JournalMolecular and Cellular Oncology
Issue number3
StatePublished - Sep 15 2014

Bibliographical note

Funding Information:
This work was supported by grants from NIH (CA125454), Mary Kay Ash Foundation, an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20 GM103527-06 (to BPZ), and American Cancer Society Research Scholar Award (RSG13187-01 to YW).

Publisher Copyright:
© 2014, © 2014 The Author(s). Published with license by Taylor & Francis Group, LLC. © 2014, © Yadi Wu and Binhua P Zhou.


  • LSD1
  • epigenetic
  • mammary carcinogenesis

ASJC Scopus subject areas

  • Molecular Medicine
  • Cancer Research


Dive into the research topics of 'Epigenetic regulation of LSD1 during mammary carcinogenesis'. Together they form a unique fingerprint.

Cite this